Orexigen Therapeutics Receives $165,000,000 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=44ba7496-b298-4942-836e-e46669701d00
Date
3/29/2016
Company Name
Orexigen Therapeutics
Mailing Address
3344 N. Torrey Pines Court La Jolla, CA 92037 USA
Company Description
OREXIGEN is studying a novel, and potentially more effective way, to achieve and sustain weight loss through a combined, two-drug approach.
Website
http://www.orexigen.com
Transaction Type
Venture Equity, Debt
Transaction Amount
$165,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. 21 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed